* Scholar Rock Holding Corp reported a quarterly adjusted loss of 66 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -53 cents. The mean expectation of nine analysts for the quarter was for a loss of 60 cents per share. Wall Street expected results to range from -65 cents to -54 cents per share.
* Reported revenue was zero; analysts expected zero.
* Scholar Rock Holding Corp's reported EPS for the quarter was a loss of 66 cents.
* The company reported a quarterly loss of $64.48 million.
* Scholar Rock Holding Corp shares had risen by 251.4% this quarter and gained 49.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 2.1% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Scholar Rock Holding Corp is $37.00 This summary was machine generated from LSEG data November 12 at 03:35 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.60 -0.66 Missed
Jun. 30 2024 -0.61 -0.60 Beat
Mar. 31 2024 -0.51 -0.59 Missed
Dec. 31 2023 -0.49 -0.50 Missed
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。